Skip to main content

Table 1 Seroprevalence of HPV16 and 18 in women with CIN 2/3 and women with normal cytology, by age group

From: Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study

Age, years

CIN2/3 (N o)

Normal cytology (N o)

HPV16 seroprevalence % (95% CI)

HPV18 seroprevalence % (95% CI)

HPV16 or 18 seroprevalence % (95% CI)

CIN 2/3

Normal cyto a

CIN 2/3

Normal cyto a

CIN 2/3

Normal cyto a

all

971

3729

      

30-39

348

708

50.6 (45.2-55.9)

28.1 (24.8-31.6)

14.4 (10.9-18.5)

10.6 (8.4-13.1)

55.2 (49.8-60.5)

32.6 (29.2-36.2)

40-49

230

517

35.2 (29.0-41.8)

23.6 (20.0-27.5)

13.9 (9.7-19.1)

7.7 (5.6-10.4)

42.6 (36.1-49.3)

27.7 (23.8-31.7)

50-59

300

1945

31.7 (26.4-37.3)

17.4 (8.8-14.2)

11.7 (8.3-15.8)

6.7 (5.6-7.9)

36.3 (42.1-60.9)

21.8 (20.0-23.7)

60-64

93

559

23.7 (15.5-33.6)

11.3 (8.8-14.2)

6.5 (2.4-13.5)

3.8 (2.3-5.7)

28.0 (19.1-38.2)

13.6 (10.9-16.7)

  1. aCyto: cytology.